We will rely on you to help lend your voice and support the biotechnology industry.
Learn more about BIO initiatives to advance the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO CEO & Investor Conference
February 12-13, 2018
BIO IP Counsels Committee Conference
April 11-13, 2018
BIO Industry Analysis Reports
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
July 16 - 19, 2018 | Philadelphia, Pennsylvania
Drawing from industry and US FDA expertise, this discussion panel, organized by the Enzyme Technical Association (ETA), will provide a general overview of the GRAS process for Industrial Biotechnology (IB) products and will review essential elements of a voluntary GRAS Notification to FDA. The panel will also discuss how microbial enzymes used as food/feed ingredients are uniquely suited to this process. Finally, recent developments in FDA’s implementation of the GRAS Final Rule will be discussed, including FDA’s draft Guidance on GRAS scientific panels and it new Guidance on the GRAS Regulatory Framework; both are expected to be helpful in preparing successful GRAS Notifications for IB products.